Pre-Tax Profit Margin (Annual)

Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues

Maravai LifeSciences Holdings, Inc. (MRVI) had Pre-Tax Profit Margin of -100.89% for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$259.19M
Net Income	$-144.85M
Cost of Goods Sold	$150.88M
Gross Profit	$108.31M
Operating Expenses	$494.80M
Operating Income	$-235.62M
Non-Operating Income/Expense	$-25.86M
Pre-Tax Income	$-261.48M
Normalized Pre-Tax Income	$-261.48M
Income after Taxes	$-259.62M
Income from Continuous Operations	$-259.62M
Consolidated Net Income/Loss	$-259.62M
Normalized Income after Taxes	$-259.62M
EBIT	$-235.62M
EBITDA	$-9.71M
Weighted-Average Shares Outstanding (Basic)	137.91M
Weighted-Average Shares Outstanding (Diluted)	137.91M
Earnings per Share (EPS) (Basic)	$-1.05
Earnings per Share (EPS) (Diluted)	$-1.05
Balance Sheet Financials
Current Assets	$429.15M
Property, Plant, and Equipment	$164.47M
Long-Term Assets	$579.10M
Total Assets	$1.01B
Current Liabilities	$56.97M
Long-Term Debt	$321.60M
Long-Term Liabilities	$374.06M
Total Liabilities	$431.04M
Common Equity	$577.21M
Tangible Shareholders Equity	$222.37M
Shareholders Equity	$577.21M
Common Shares Outstanding	252.66M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$7.46M
Cash Flow from Investing Activities	$-24.32M
Cash Flow from Financial Activities	$-235.71M
Beginning Cash	$574.96M
End Cash	$322.40M
Increase/Decrease in Cash	$-252.56M
Stock-Based Compensation	$49.41M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.53
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	0.57
Gross Margin	41.79%
Operating Margin	-90.91%
EBIT Margin	-90.91%
EBITDA Margin	-3.74%
Pre-Tax Profit Margin	-100.89%
Profit Margin	-55.89%
Free Cash Flow	$-22.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	3.01
Receiveable Turnover	6.73
Days Sales in Receivables	54.25
Return on Equity	-44.98%
Return on Tangible Equity	-116.75%
Return on Assets	-25.75%
Return on Investments	-28.89%
Book Value Per Share	$2.28
Free Cash Flow per Share	$-0.16
Operating Cash Flow per Share	$0.05

Data from Zacks Investment Research, Inc.